January 2016 in “SHILAP Revista de lepidopterología” This paper presents a case where alopecia was associated with the use of escitalopram and improved after switching to duloxetine, alongside a literature review of antidepressant-related alopecia.
2 citations
,
March 2016 in “Düşünen Adam” This case report describes alopecia associated with escitalopram use, which improved upon switching to duloxetine, and examines existing literature on antidepressant-related hair loss.
1 citations
,
January 2021 in “European Journal of Inflammation” In this study, naringenin and its methylated derivatives reduced depression-like behaviors and inflammation markers in mice exposed to finasteride, suggesting their potential as effective and safe anti-depressive agents.
March 2026 in “Frontiers in Bioscience-Elite” This study found that duloxetine and escitalopram exhibited broad-spectrum antimicrobial activity, while buspirone had selective effects, and finasteride disrupted yeast virulence traits, suggesting these drugs could be repurposed as antimicrobial therapies.
February 2010 in “Acta Obstetricia et Gynecologica Scandinavica” This collection of articles in AOGS includes findings on tetranectin as a possible prognostic marker for advanced ovarian cancer, and the effectiveness of tension-free vaginal tape for recurrent stress urinary incontinence.